Immunological dysregulation after bone-marrow transplantation in patients with severe combined immunodeficiency

Case Reports

J L Virelizier et al. Pathol Biol (Paris). 1978 Jan.

. 1978 Jan;26(1):21-2.

No abstract available

Similar articles

Bone marrow transplanation for severe combined immunodeficiency with the HL-A-incompatible but MLC-identical mother as a donor.
Neithammer D, Goldmann SF, Haas RJ, Dietrich M, Flad HD, Fliedner TM, Kleihauer E. Neithammer D, et al. Transplant Proc. 1976 Dec;8(4):623-8. Transplant Proc. 1976. PMID: 11594 No abstract available.
Bone marrow transplantation: cellular engineering to correct primary immunodeficiency, aregenerative anemia and pancytopenia.
Good RA. Good RA. Birth Defects Orig Artic Ser. 1975;11(1):377-9. Birth Defects Orig Artic Ser. 1975. PMID: 238679 No abstract available.
Fetal liver transplantation in two infants with severe combined immunodeficiency.
Aiuti F, Businco L, Fiorilli M, De Martino M, Vierucci A. Aiuti F, et al. Transplant Proc. 1979 Mar;11(1):230-4. Transplant Proc. 1979. PMID: 377637 No abstract available.
Severe combined immunodeficiency: transplantation approaches for patients lacking an HLA genotypically identical sibling.
O'Reilly RJ, Pahwa R, Dupont B, Good RA. O'Reilly RJ, et al. Transplant Proc. 1978 Mar;10(1):187-99. Transplant Proc. 1978. PMID: 345560 Review. No abstract available.
[Present status of treatment of immunodeficiency with special reference to cellular immunologic deficiency].
Goya N. Goya N. Nihon Rinsho. 1973 Dec;31(12):3441-7. Nihon Rinsho. 1973. PMID: 4151659 Review. Japanese. No abstract available.